Hisamitsu Pharmaceutical: Confirmatory letter.
Hisamitsu Pharmaceutical: Quarterly report - Q1 of the 123rd period (03/01/2024 to 05/31/2024)
Hisamitsu Pharmaceutical: February 2025, First quarter financial statements by Japanese standard (consolidated).
Hisamitsu Pharmaceutical: Confirmation letter
Hisamitsu Pharmaceutical: Financial Report - 122nd Term (2023/03/01 - 2024/02/29)
Hisamitsu Pharmaceutical: Extraordinary Report
Hisamitsu Pharmaceutical: Financial Results for the Fiscal Year Ending February 2024 [Japanese GAAP] (Consolidated)
Hisamitsu Pharmaceutical: Confirmation letter
Hisamitsu Pharmaceutical: Quarterly Report - 122nd Quarter 3rd Quarter (2023/09/01 to 2023/11/30)
Hisamitsu Pharmaceutical: Notice regarding revisions to earnings forecasts
Hisamitsu Pharmaceutical: Summary of financial results for the 3rd quarter of the fiscal year ending February 2024 [Japanese GAAP] (consolidated)
Hisamitsu Pharmaceutical: Confirmation letter
Hisamitsu Pharmaceutical: Quarterly Report - 122nd Quarter (2023/06/01-2023/08/31)
Hisamitsu Pharmaceutical: Summary of Financial Results for the 2nd Quarter Ending February 2024 [Japanese GAAP] (Consolidated)
Hisamitsu Pharmaceutical: Confirmation letter
Hisamitsu Pharmaceutical: Quarterly Report - 122nd Quarter (2023/03/01-2023/05/31)
Hisamitsu Pharmaceutical: Summary of Financial Results for the First Quarter of the Fiscal Year Ending February 2024 [Japanese GAAP] (Consolidated)
Hisamitsu Pharmaceutical: Confirmation letter
Hisamitsu Pharmaceutical: Securities Report - 121st Period (2022/03/01 - 2023/02/28)
Hisamitsu Pharmaceutical: Extraordinary Report
No Data
No Data